All articles tagged: Dermatology
MedScape
06 September at 04.21 PM
Not Kidding: Yellow Dye 5 May Be the Key to InvisibilityA common food dye turned mice see-through, a "stunning" finding that could revolutionize imaging techniques in medicine. |
MedScape
06 September at 10.10 AM
Vitiligo: Combination Therapies and Emerging TreatmentsIt can take up to 1 year to see a significant response with topical immunosuppressants and narrowband ultraviolet B treatment. |
MedScape
06 September at 09.06 AM
Metformin May Help Manage Scarring Alopecia, Study SuggestsLow-dose oral metformin was associated with symptomatic improvement, hair regrowth, and gene expression modulation in a case series of patients with treatment-refractory central centrifugal cicatricial alopecia. |
MedScape
05 September at 09.33 AM
Study Finds Skin Cancer Risk Increased in US VeteransThe risk for any skin cancer was higher among US veterans than among nonveterans, according to a cross-sectional study using nationally representative data collected over 20 years. |
MedScape
05 September at 02.48 AM
How Do Tapinarof, Roflumilast Creams Fit Into Psoriasis Rx?Both nonsteroidal options are fast-acting, Jashin J. Wu said. |
HealthDay
04 September at 03.03 PM
Link Between n-3 LCPUFA, Eczema Varies by Maternal COX1 GenotypeThe association of prenatal ω-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) with the risk for childhood atopic dermatitis (AD) varies based on the maternal cyclooxygenase-1 (COX1) genotype, according to a study published online Aug. 28 in JAMA Dermatology.Liang Chen, from Herlev and Gentofte Hospital in Copenhagen, Denmark, an |
MedScape
04 September at 05.35 AM
Study Characterizes Skin Toxicity With Uveal Melanoma RxNearly 80% of patients with uveal melanoma treated with tebentafusp experienced skin reactions in a small cohort study. |
MedScape
04 September at 03.17 AM
Topical Timolol an Option for Treating Pyogenic GranulomaSeveral case reports about the use of topical timolol for PG have been published in the medical literature, including a case series. |
HealthDay
03 September at 08.05 PM
Global Study Reveals Widespread Micronutrient DeficienciesMore than 5 billion people globally do not consume enough iodine, vitamin E, and calcium, according to a study published online Aug. 29 in The Lancet Global Health.Simone Passarelli, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues estimated micronutrient intake using a novel approach accounting for t |
MedScape
02 September at 09.11 AM
Study Assesses Childhood Cancer Survivors' Risk for KCsThis study "provides the largest longitudinal profile" of keratinocyte carcinomas in childhood cancer survivors to date, according to the authors. |
MedScape
02 September at 08.43 AM
Can Prenatal Fish Oil Reduce AD Risk in Children?The mother's COX1 genotype could influence whether prenatal fish oil supplementation affects the risk for atopic dermatitis in children, a study found. |
MedScape
02 September at 04.21 AM
Vitiligo Linked to Psychiatric Conditions in Black ChildrenA study found a significantly higher risk for several psychiatric disorders in Black children with vitiligo. |
HealthDay
30 August at 03.06 PM
Dietary Vitamin E May Be Protective Against Atopic DermatitisDietary intake of vitamin E may potentially lower the risk for atopic dermatitis, according to a study published online Aug. 9 in Skin Research & Technology.Siqing Wang, from the Beijing University of Chinese Medicine, and colleagues conducted a Mendelian randomization analysis to explore the causal relationship between dietary |
MedScape
30 August at 02.38 AM
Impact of Neurofibromatosis on Quality of Life EvaluatedA crowdsourced registry study found associations between features of cutaneous neurofibromas and quality of life in patients with neurofibromatosis type 1. |
MedScape
30 August at 01.40 AM
Laser Treatment for Acne: Results From 100 PatientsThe protocol included three laser treatments spaced 3-4 weeks apart combined with medical therapy and other energy-based devices. |
HealthDay
29 August at 03.46 PM
People With Xylazine Wounds Face Barriers to Seeking Wound CarePeople with self-identified xylazine wounds are more likely to engage in subcutaneous injection and face several barriers to seeking medical wound treatment, according to a study published online Aug. 21 in Drug and Alcohol Dependence.Raagini Jawa, from the University of Pittsburgh School of Medicine, and colleagues sought to und |
HealthDay
27 August at 09.50 PM
Team-Based Documentation Can Increase Visit Volume, Cut Documentation TimePhysicians who adopt team-based documentation, defined as use of coauthored documentation with another clinical team member, experience increased visit volume and reduced documentation time, according to a study published online Aug. 26 in JAMA Internal Medicine.Nate C. Apathy, Ph.D., from the University of Maryland School of Public He |
HealthDay
27 August at 03.52 PM
Childhood Obesity Tied to Pediatric Immune-Mediated Skin DiseasesEarly childhood obesity may increase the risk for pediatric immune-mediated skin diseases, according to a study published online Aug. 21 in the Journal of Investigative Dermatology.Seong Rae Kim, M.D., from the Seoul National University College of Medicine in South Korea, and colleagues examined associations between body mass inde |
MedScape
26 August at 07.36 AM
iPLEDGE Reforms: Are Changes Imminent? Timeline UnclearThe timeline for when an improved program might be in place remains unclear. |
MedScape
26 August at 06.44 AM
TYK2 Inhibitor Shows Promise for Moderate, Severe PsoriasisZasocitinib showed significant efficacy in treating moderate to severe psoriasis, with 67%-68% of patients on higher doses achieving a PASI 75 score at 12 weeks. |
MedScape
22 August at 11.33 PM
Quitting Smoking Reduces HS Risk After 3 YearsSmoking cessation reduced the risk for hidradenitis suppurativa, eventually aligning with the risk for never smokers. |
HealthDay
22 August at 09.33 AM
Americans Have Mixed Feelings About AI in Health Care, Poll FindsMost Americans believe artificial intelligence should be used to improve health care, a new national survey reports.However, many are still a little queasy over some of the implications of widespread AI use, the <a href="https://wexnermedical.osu |
HealthDay
21 August at 03.11 PM
Collagen Peptide Beverage Beneficial for Skin Health in Young WomenA beverage containing collagen peptides (CP), including tripeptides and elastin peptides (EP), is beneficial for the skin health of young and middle-aged women, according to a study published in the June issue of the Journal of Dermatologic Science and Cosmetic Technology.Shan Lu, from the Shenzhen Porshealth Bioengineering Co. in Ch |
MedScape
21 August at 12.26 PM
Laser Treatment of Nonmelanoma Skin Cancer on the RiseA seminal study from 2017 laid the groundwork for current approaches, Elizabeth Tanzi, MD, said. |
MedScape
20 August at 05.00 AM
Dermatologist Offers Best Practices for Social Media PostsDeciding which platforms to use and what voice or tone to adopt requires some soul-searching, according to Jessica G. Labadie, MD. |
MedScape
19 August at 06.04 AM
Who's Performing Cosmetic Procedures at MedSpas?The top two procedures performed by the surveyed MedSpas are facials and hair removal. |
HealthDay
16 August at 09.21 PM
Skin of Color Has More Adverse Events From SclerotherapyPatients with skin of color may experience more adverse events from sclerotherapy, according to a study published online July 26 in the Journal of the American Academy of Dermatology.Michelle Lazar, from the Boston University School of Medicine, and colleagues characterized the incidence of common adverse events following sclerothe |
MedScape
16 August at 07.49 AM
Managing Orofacial Changes in SclerodermaThe recommended treatment for patients with scleroderma was to use nerve blocks for injecting HA filler or hyaluronidase and to minimize the injection points. |
HealthDay
15 August at 10.00 PM
FDA Approves Nemluvio for Prurigo NodularisThe U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for adult patients living with prurigo nodularis.Nemluvio, administered as a prefilled pen for subcutaneous injection, inhibits interleukin-31 cytokine signaling, which is known to drive itch and is involved in inflammation, altered epidermal differentiation, and fibrosi |
HealthDay
14 August at 03.45 PM
Clinicians Are Interested in Climate Change EducationMost clinicians show positive attitudes toward education in climate change, according to a study published online Aug. 8 in JAMA Network Open.Wynne Armand, M.D., from the Center for the Environment and Health at Massachusetts General Hospital in Boston, and colleagues evaluated whether a quality incentive program measure for cli |
MedScape
14 August at 11.00 AM
Alopecia: What Happens When Baricitinib Responders Stop Rx?Continuous treatment with baricitinib is needed to maintain hair regrowth in patients with severe alopecia areata. |
MedScape
14 August at 11.00 AM
Dermatomyositis: Age at Dx, Signs Differ in HispanicsA study identified distinct clinical features and other differences in Hispanic patients with dermatomyositis compared with non-Hispanic patients. |
MedScape
13 August at 11.30 AM
FDA Approves Nemolizumab for Prurigo NodularisThe interleukin-31 inhibitor is also under FDA review for treating atopic dermatitis. |
MedScape
13 August at 08.21 AM
Recommendations on Managing Cutaneous Side Effects of ICIsCutaneous immune-related adverse events (cirAEs) are the most frequently reported and most visible adverse effects of checkpoint inhibition. |
HealthDay
12 August at 03.54 PM
Dupilumab Maintains Its Effectiveness Up to Five Years in Patients With EczemaFor patients with atopic dermatitis (AD), dupilumab maintains its clinical effectiveness up to five years and is discontinued by 23.8 percent of patients, according to a study published online Aug. 7 in JAMA Dermatology.Celeste M. Boesjes, M.D., from the University Medical Center Utrecht in the Netherlands, and colleagues examined clini |
HealthDay
12 August at 03.47 PM
Gene Expression Signature Predicts Immune-Related Adverse Events in Melanoma PatientsA gene expression signature in peripheral CD4+ T-cells can predict severe immune-related adverse events (irAEs) among melanoma patients treated with ipilimumab/nivolumab, according to a study published online Aug. 8 in Clinical Cancer Research.Kelsey R. Monson, Ph.D., from the Perlmutter Cancer Center at NYU Langone Health in |
HealthDay
12 August at 03.44 PM
Commonly Prescribed Antibiotics Linked to Cutaneous Adverse Drug ReactionsSulfonamide antibiotics and cephalosporins are most strongly associated with serious cutaneous adverse drug reactions (cADRs), according to a study published online Aug. 8 in the Journal of the American Medical Association.Erika Y. Lee, M.D., from the University of Toronto, and colleagues explored the risk for serious cADRs associated w |
HealthDay
09 August at 03.37 PM
Racial Differences Identified in Frequency of Biopsy for PsoriasisThere are racial differences in the frequency of skin biopsy for psoriasis, indicating diagnostic uncertainty, according to a research letter published online Aug. 7 in JAMA Dermatology.Fahad Ahmed, from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues conducted a cross-sectional study inv |
HealthDay
08 August at 03.42 PM
ChatGPT Only Gets Diagnoses Correct Half of the TimeChatGPT is not accurate as a diagnostic tool, but does offer some medical educational benefits, according to a study published online July 31 in PLOS ONE.Ali Hadi, from the Schulich School of Medicine and Dentistry at Western University in London, Ontario, Canada, and colleagues investigated ChatGPT’s diagnostic accuracy and utili |
HealthDay
08 August at 11.41 AM
New Strain of Mpox Spreading in Africa Has CDC ConcernedU.S. doctors should be on the lookout for a more severe strain of mpox that is spreading widely in parts of Africa, federal health officials warned Wednesday.The alert, issued by the U.S. Centers for Disease Control and Prevention, came just hours after the World Health Org |
HealthDay
06 August at 11.04 PM
Alopecia Tied to Higher Prevalence of Autoimmune, Psychiatric ComorbiditiesPatients with alopecia areata (AA) have a higher prevalence of autoimmune and psychiatric comorbidities at time of diagnosis as well as a higher risk for new-onset autoimmune and psychiatric comorbidities after diagnosis, according to a study published online July 31 in JAMA Dermatology.Arash Mostaghimi, M.D., M.P.H., from Brigham |
HealthDay
02 August at 10.52 PM
FDA Approves Leqselvi for Severe AlopeciaThe U.S. Food and Drug Administration has approved Leqselvi (deuruxolitinib) tablets for the treatment of adults with severe alopecia areata.Leqselvi (8 mg) is a twice-daily oral selective inhibitor of the Janus kinases JAK1 and JAK2. In trials, the three most common adverse events were headache, acne, and nasopharyngitis.The approval was |
HealthDay
01 August at 09.37 PM
FDA Warns Against Using Chemical Peels Without Professional SupervisionThe U.S. Food and Drug Administration is warning that chemical peels should not be used without the supervision of a dermatologist or other trained professional."FDA is warning consumers not to purchase or use certain chemical peel skin products without appropriate professional supervision due to risk of serious skin injuries," the agency said |
HealthDay
01 August at 04.11 PM
CDC Report Addresses Nonfinancial Access Barriers to Care in 2022Nonfinancial access barriers to care represent a persistent problem in the United States, with more than 12 percent of adults reporting being too busy to go to a provider, according to a study published online Aug. 1 in the National Health Statistics Reports, a publication from the National Center for Health Statistics.Amanda E. N |
HealthDay
01 August at 03.59 PM
Relatively High Frequency of Emergency Complications Seen for Dermatological ProceduresA relatively high proportion of dermatologists experience emergency complications during dermatological, surgical, or cosmetic procedures, according to a study published online July 20 in the Journal of Cosmetic Dermatology.Hilal Kaya Erdogan, M.D., from Eskişehir Osmangazi University in Turkey, and colleagues conducted a cross-section |
HealthDay
30 July at 08.54 PM
Gen Z Perceives Atopic Dermatitis to Be More SevereGeneration Z (Gen Z) patients present with a higher subjective perception of atopic dermatitis severity than millennial generation patients, according to a study published online July 25 in the International Journal of Dermatology.Clara Ureña-Paniego, from the University of Granada in Spain, and colleagues compared the clinical se |
HealthDay
29 July at 07.12 PM
Atopic Dermatitis Has Large Impact on Sexual Function Among WomenMost women with atopic dermatitis have impairment in sexual function, and about half consider that atopic dermatitis may influence their reproductive desire, according to a study published online June 11 in Acta Dermato-Venereologica.Juan-Angel Rodriguez-Pozo, from the Virgen de las Nieves University Hospital in Granada, Spain, and coll |
HealthDay
29 July at 03.30 PM
Psoriasis, Psoriatic Arthritis Tied to Higher Risk of PolyneuropathyPsoriasis and psoriatic arthritis may be associated with an increased risk of polyneuropathy, according to a study published online June 28 in Muscle & Nerve.Pietro E. Doneddu, M.D., from the IRCCS Humanitas Research Hospital in Milan, and colleagues evaluated the risk and features of peripheral neuropathy in patients with psor |
HealthDay
26 July at 03.50 PM
Hydroxychloroquine Safe, Effective Treatment for Anogenital Lichen SclerosusHydroxychloroquine appears to be a safe and effective treatment option for anogenital lichen sclerosus that only has mild adverse effects, according to a study published online July 19 in the International Journal of Dermatology.Christeebella O. Akpala, from the Mayo Clinic in Rochester, Minnesota, and colleagues analyzed the demog |
HealthDay
24 July at 03.23 PM
Adverse Event Risk Up for >90 Days Versus >30 Days of Corticosteroids for EczemaUse of oral corticosteroids for >90 days during one year is associated with a slightly increased risk of adverse events (AEs), according to a study published online July 19 in JAMA Network Open.Yong Hyun Jang, M.D., Ph.D., from Kyungpook National University in Daegu, South Korea, and colleagues examined the association betwee |
HealthDay
19 July at 10.52 PM
Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual AdultsWith respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study published online July 17 in JAMA Dermatology.Katelyn J. Rypka, from the University of Minnesota in Minneapolis, and colleagues examined differences in the lifetime |
HealthDay
19 July at 03.42 PM
Dose Requirements for Glabellar Botulinum Toxin Higher in High-Sun ClimateTo achieve maximal paralysis, patients injected with glabellar botulinum toxin may have significantly higher dose requirements in a high sun-exposure environment, according to a study published in the July issue of Plastic and Reconstructive Surgery.Kim L. Borsky, M.B.B.S., M.D., from the Stoke Mandeville Hospital in the United Kingdom, |
HealthDay
18 July at 04.04 PM
Air Pollution Exposure Tied to New PsoriasisLong-term exposure to air pollution is associated with the development of new psoriasis, according to a study published online July 16 in JAMA Network Open.Junhui Wu, Ph.D., from the Peking University School of Nursing in Beijing, and colleagues examined the association between long-term exposure to air pollution and psoriasis an |
HealthDay
16 July at 10.52 PM
Direct CGRP Inhibition Cuts Acne, Rosacea in Patients With MigraineFor patients experiencing migraine, direct calcitonin gene-related peptide (CGRP) inhibition with monoclonal antibodies (mAbs) is associated with reduced rates of acne and rosacea compared with no inhibition (topiramate) or indirect inhibition (triptans), according to a research letter published online July 10 in JAMA Dermatology.Chris |
HealthDay
12 July at 10.23 PM
CDC Reports Seven Cases of Illness After Possible Counterfeit Botox InjectionsSeven patients with illness identified after presumed cosmetic botulinum neurotoxin (BoNT) product injection are described in a case report published in the July 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Christine M. Thomas, D.O., from the CDC in Atlanta, and colleagues charact |
HealthDay
12 July at 10.21 PM
More Women Than Men Experience Nonphysical Violence in Health Care WorkforceWomen in the health care workforce are more likely to experience verbal abuse, sexual harassment, and bullying, while men are more likely to experience physical violence, according to a study published online July 2 in PLOS Global Public Health.Sioban Nelson, R.N., Ph.D., from the University of Toronto, and colleagues conducted a scopin |
HealthDay
11 July at 10.11 PM
FDA Approves Zoryve for Atopic DermatitisThe U.S. Food and Drug Administration has approved Zoryve (roflumilast) cream, 0.15 percent, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).Zoryve is a once-daily, steroid-free cream that the company says will be available at the end of July.The approval was based on resu |
HealthDay
10 July at 04.06 PM
Adherence to Mediterranean Diet, Omega-3 Fatty Acids Beneficial in AcneAdherence to a Mediterranean diet incorporating eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) reduces skin lesions and improves quality of life in patients with acne, according to a study published online July 10 in the Journal of Cosmetic Dermatology.Anne Guertler, M.D., from Ludwig Maximilian University in Munich, and |
HealthDay
09 July at 03.45 PM
Rural Residents Continue to Have Higher Odds of Skin CancerUrban-rural disparities in skin cancer prevalence continue to persist, according to a study published in the June issue of the Journal of Drugs in Dermatology.Rachel R. Lin, from the University of Miami Miller School of Medicine, and colleagues used data from the Behavior Risk Factor Surveillance Survey (2018 to 2021) to compare th |
HealthDay
05 July at 02.26 PM
Postpandemic Physician Revenue Recovery Varies by Specialty, Practice TypePandemic-associated physician revenue recovery in 2021 and 2022 varied by specialty and practice type, according to a study published in the July issue of Health Affairs.Ravi B. Parikh, M.D., from the University of Pennsylvania in Philadelphia, and colleagues assessed pandemic-related impact on physician revenue (2020 to 2022) and h |
HealthDay
02 July at 04.01 PM
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 MillionThe mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are considered, according to a study published online June 28 in JAMA Network Open.Aylin Sertkaya, Ph.D., from Eastern Research Group Inc., in Lexington, Massachusetts, and colleagues ass |
HealthDay
01 July at 03.16 PM
Psoriasis, With or Without Psoriatic Arthritis, Associated With FatiguePsoriasis is associated with fatigue, especially among those with psoriatic arthritis (PsA), according to a study published in the July issue of the Journal of the American Academy of Dermatology.Lea Nymand, from Bispebjerg Hospital and the University of Copenhagen in Denmark, and colleagues explored the characteristics of fatigue and it |
HealthDay
01 July at 03.04 PM
Few Patients With Positive Margins After Basal Cell Excision Have RecurrenceAmong patients with incompletely excised basal cell carcinoma (BCC), only about 16 percent with positive histopathologic margins have clinical recurrence, according to a study published online June 13 in Dermatology.Maria Daviti, M.D., from Aristotle University in Thessaloniki, Greece, and colleagues reported the real-life management of |
HealthDay
25 June at 09.42 PM
Abrocitinib Effective, Tolerated for Prurigo Nodularis, Chronic PruritusFor patients with prurigo nodularis (PN) and chronic pruritus of unknown origin (CPUO), abrocitinib, a Janus kinase 1 inhibitor, is effective and well tolerated, according to a study published online June 5 in JAMA Dermatology.Shawn G. Kwatra, M.D., from the University of Maryland School of Medicine in Baltimore, and colleagues examine |
HealthDay
24 June at 03.02 PM
Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in MelanomaFor patients with resected stage III melanoma, adjuvant therapy with dabrafenib plus trametinib is associated with a nonsignificant benefit in terms of overall survival, according to a study published online June 19 in the New England Journal of Medicine.Georgina V. Long, M.D., Ph.D., from the University of Sydney, and colleagues random |
HealthDay
20 June at 08.56 PM
2021 to 2022 Saw Decrease in Telemedicine Use in Past 12 MonthsFrom 2021 to 2022, there was a decrease in the percentage of adults who used telemedicine in the past 12 months, according to the June 20 National Vital Statistics Reports, a publication from the National Center for Health Statistics.Jacqueline W. Lucas, M.P.H., and Xun Wang, from the National Center for Health Statistics in Hyattsvil |
HealthDay
18 June at 09.11 PM
Approximately 7 Percent of U.S. Population Uninsured in 2023In 2023, 7.6 percent of the U.S. civilian noninstitutionalized population was uninsured, according to early estimates from the National Health Interview Survey, 2023, released by the National Center for Health Statistics.Robin A. Cohen, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from |
HealthDay
18 June at 03.44 PM
Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment EffectLebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to week 52 following withdrawal of treatment, according to a study presented at the annual Revolutionizing Atopic Dermatitis Conference, held from June 8 to 10 in Chicago.Jonathan I. Silverberg, M.D., Ph.D., M.P.H., from the George Washington Unive |
HealthDay
18 June at 09.50 AM
Pandemic-Era Tax Credits Made Healthcare More Affordable, But They're Set to ExpireIn a success story for Americans seeking affordable healthcare coverage, tax credits put in place during the pandemic helped millions gain health insurance, a new report found.Trouble is, the credits are set to expire at the end of 2025, noted a research team from the nonprofit Robert Wood Johnson Foundation (RWJ).According to RWJ's <a h |
HealthDay
14 June at 03.32 PM
No Evidence That Live Vaccines Are Unsafe for Patients on DupilumabThere is no evidence to suggest that administration of live vaccines to patients receiving dupilumab is unsafe, and vaccine efficacy is not affected by dupilumab, according to a position paper published online June 5 in the Annals of Allergy, Asthma & Immunology.Noting that dupilumab targets the interleukin (IL)-4 receptor alpha sub |
HealthDay
13 June at 10.58 PM
Health Care Spending Growth Projected to Outpace GDP to 2032Health care spending growth is projected to outpace that of the gross domestic product (GDP) during the coming decade, according to a study published online June 12 in Health Affairs.Jacqueline A. Fiore, Ph.D., from the Centers for Medicare & Medicaid Services in Baltimore, and colleagues projected growth in national health expend |
HealthDay
12 June at 03.05 PM
Adverse Effects of Medical Treatment Increasing WorldwideThe burden of adverse effects of medical treatment (AEMT) is increasing, with the proportion of all cases accounted for by the increasing rates seen in older adults, according to a study published online June 11 in BMJ Quality & Safety.Liangquan Lin, from the Chinese Academy of Medical Sciences & Peking University Medical Col |
HealthDay
07 June at 03.33 PM
Isotretinoin Effective for Acne in Those Receiving Gender-Affirming TherapyIsotretinoin is well tolerated and effective for individuals receiving masculinizing gender-affirming hormonal therapy who have acne, according to a study published online May 29 in JAMA Dermatology.James Choe, from Brigham and Women's Hospital in Boston, and colleagues examined clinical outcomes of isotretinoin among transgender and gen |
HealthDay
06 June at 10.28 PM
CDC Urges Clinicians to Remain on the Lookout for Mpox Virus InfectionsAmong emergency department patients evaluated for an mpox-compatible rash, the prevalence of mpox is 1.5 percent, according to research published in the June 6 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Carl T. Berdahl, M.D., from Cedars-Sinai Medical Center in Los Angeles, and co |
HealthDay
05 June at 03.28 PM
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable MelanomaNeoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among patients with resectable, macroscopic stage III melanoma, according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the American Soc |
HealthDay
03 June at 09.12 PM
9.6 Percent of Medical Visits Took Place Via Telehealth in 2021In 2021, 9.6 percent of medical visits took place via telehealth, with a higher percentage seen for mental health visits, according to a research letter published online June 4 in the Annals of Internal Medicine.Sandra L. Decker, Ph.D., from the Agency for Healthcare Research and Quality in Rockville, Maryland, and colleagues describe te |
HealthDay
31 May at 03.46 PM
1.5 Percent Ruxolitinib Cream Safe, Effective for Teens With EczemaLong-term intermittent use of ruxolitinib cream is well tolerated and provides disease control in adolescent patients with atopic dermatitis (AD), according to a study published online May 2 in the American Journal of Clinical Dermatology.Lawrence F. Eichenfield, M.D., from the University of California San Diego, and colleagues asse |
HealthDay
30 May at 04.04 PM
Bimekizumab Yields Meaningful Response in Hidradenitis SuppurativaBimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published online May 22 in The Lancet.Alexa B. Kimball, M.D., from the Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, and colleagues examined the efficacy and safety of b |
MedScape
30 May at 07.18 AM
Most Chronic Wounds Not Managed by Dermatologists"By examining national trends in patient visits and treatment, we may be able to better inform healthcare utilization for cutaneous wounds," Chandy said. |
MedScape
30 May at 06.51 AM
Psoriasis Tied to Increased Risk for MACE Despite Statin UseThe finding "highlights the need for further research into tailored treatments for cardiovascular risk in psoriasis patients," Ana Ormaza Vera said. |
MedScape
29 May at 11.10 PM
Study Addresses Racial/Ethnic Disparities in Psoriasis RxBlack patients with psoriasis had the lowest rate of switching to another biologic therapy compared with other racial and ethnic groups, suggesting possible disparities in treatment patterns. |
HealthDay
29 May at 09.17 PM
2007 to 2019 Saw Increase in Inflation-Adjusted Health Care SpendingFrom 2007 to 2019, there was an increase in inflation-adjusted health care spending, largely due to increasing contributions to premiums, according to a research letter published online May 28 in JAMA Internal Medicine.Sukruth A. Shashikumar, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues conducted a cro |
MedScape
29 May at 03.36 AM
Dupilumab: Future Treatment for Pediatric Alopecia Areata?Dupilumab will be compared with placebo in a larger multicenter randomized trial of children with alopecia. |
MedScape
29 May at 03.07 AM
Tapinarof Cream Effective For AD, Down to Age 2 YearsResults from two phase 3 trials showed that topical tapinarof, once a day, was effective and safe in patients with atopic dermatitis as young as 2 years old. |
HealthDay
28 May at 03.08 PM
Parental E-Cigarette Use Linked to Increase in Pediatric Atopic DermatitisParental electronic cigarette use is associated with increased odds of pediatric atopic dermatitis (AD), according to a research letter published online May 22 in JAMA Dermatology.Gun Min Youn, from the Stanford University School of Medicine in California, and colleagues conducted a retrospective cross-sectional analysis of the 2014 to |
MedScape
27 May at 03.26 AM
Parental e-Cigarette Use May Increase AD Risk in ChildrenParental e-cigarette use was associated with an increased risk for pediatric atopic dermatitis in a retrospective, cross-sectional analysis of US population data. |
MedScape
27 May at 02.51 AM
Eczema Risk Increased in Older Adults on AntihypertensivesUse of antihypertensive drugs was associated with a small increase in the rate of eczematous dermatitis diagnoses in older adults, with varying risks with different classes. |
HealthDay
24 May at 04.06 PM
Antihypertensives Linked to Eczematous Dermatitis in SeniorsAntihypertensive drugs are associated with an increased risk for eczematous dermatitis in older adults, and the effect sizes are largest for diuretics and calcium channel blockers, according to a study published online May 22 in JAMA Dermatology.Morgan Ye, M.P.H., from the University of California in San Francisco, and colleagues examine |
MedScape
24 May at 06.28 AM
Study Reveals Diverse Skin Manifestations in HemochromatosisAn iron profile workup and dermatological findings, such as hyperpigmentation, resistant pruritus, alopecia, and vitiligo, can help diagnose hemochromatosis. |
MedScape
23 May at 06.32 AM
High-Stage cSCC: Outcomes Superior With Mohs vs WLE"Our hope is that these findings provide additional data to support Mohs as the standard of care for primary surgical treatment of high-stage cSCC," the study's lead author said. |
HealthDay
22 May at 03.50 PM
Global Life Expectancy, Disease Burden Set to Keep ImprovingLife expectancy and age-standardized disease burden are expected to continue improving between 2022 and 2050, according to the Global Burden of Disease (GBD) study, published in the May 18 issue of The Lancet.Stein Emil Vollset, M.D., M.P.H., and colleagues from the GBD 2021 Forecasting Collaborators provide a reference forecast and a |
MedScape
22 May at 11.00 AM
Top Tools for Measuring AD in Clinical Practice RecommendedConsensus was reached during an in-person meeting attended by 34 individuals with diverse backgrounds. |
MedScape
22 May at 04.53 AM
Home Phototherapy for Psoriasis: Optimizing AccessThe ideal candidate "is averse to using systemic agents but whose disease is beyond the point where topical medicines alone will work," Craig A. Elmets, MD, said. |
HealthDay
21 May at 10.56 PM
Acrochordons May Be Marker for Metabolic Disease in ChildrenIn pediatric patients, acrochordons may be a marker for metabolic disease, according to a study published online April 29 in Pediatric Dermatology.Rachel K. Greene, M.D., from the University of Michigan in Ann Arbor, and colleagues conducted a single-center retrospective cohort study of outpatient dermatology patients between Jan. 1, 20 |
MedScape
20 May at 11.57 PM
Study Finds Radiotherapy for NMSC in Dermatology GrowingThere is persistent growth in eBT/SRT by a small but expanding proportion of general dermatologists. |
HealthDay
20 May at 03.58 PM
Individuals With BAP1 Have High Rate of Nail AbnormalitiesIndividuals with BRCA1-associated protein (BAP1) have a high rate of nail abnormalities consistent with onychopapillomas, according to a study published online May 17 in JAMA Dermatology to coincide the annual meeting of the Society for Investigative Dermatology, held from May 15 to 18 in Dallas.Alexandra Lebensohn, from the Nat |
MedScape
20 May at 03.03 AM
Chart Review Highlights Unique AD Features in Older PatientsMore research is "needed to elucidate the unique features of elderly AD in pathophysiology and optimal treatments," the study authors wrote. |
MedScape
19 May at 11.07 PM
Study Identifies Several Onychomycosis Risk FactorsTinea pedis, chronic kidney disease, peripheral vascular disease, and type 2 diabetes were associated with an increased risk for onychomycosis in patients with onychodystrophy. |
MedScape
16 May at 09.26 AM
Skin Tags Linked to Metabolic Syndrome in ChildrenAcrochordons (skin tags) in children and adolescents may serve as a marker for metabolic diseases. |
MedScape
16 May at 09.23 AM
Wits of Pediatric Dermatologists Pitted Against ChatGPTOverall, version 4.0 of the AI tool performed better than version 3.5. |
MedScape
16 May at 05.10 AM
Tranexamic Acid Injection Reduces Bleeding After MohsAdverse effects associated with using the antifibrinolytic were rare. |
HealthDay
15 May at 07.29 PM
Non-Hispanic Black Melanoma Patients Present With Advanced DiseaseNon-Hispanic Black (NHB) melanoma patients have distinct tumor characteristics, presenting with more advanced disease and exhibiting worse outcomes, according to a study published in the May issue of the Journal of Surgical Oncology.Jessica A. Steadman, M.B.B.S., from the Mayo Clinic in Rochester, Minnesota, and colleagues examined fe |
HealthDay
15 May at 03.45 PM
AACR Delivers Report on Disparities in Cancer ProgressIn its biennial Cancer Disparities Progress Report published today, the American Association for Cancer Research presents the latest statistics on disparities in cancer progress experienced by ethnic-minority groups and other medically underserved populations in the United States.Robert A. Winn, M.D., from the Virginia Commonwealth Un |
MedScape
14 May at 10.13 AM
US Study Delves Into Risk Factors for MelasmaExposure to hormones, hyperpigmenting drugs, and multiparity increased risk for melasma across different racial groups in a US study of a diverse population. |
HealthDay
13 May at 10.34 PM
Physicians With Disabilities May Experience DepersonalizationPhysicians with disabilities (PWDs) are significantly more likely to experience depersonalization but not emotional exhaustion when compared with their peers without disabilities, according to a research letter published online May 9 in JAMA Network Open.Lisa M. Meeks, Ph.D., from the University of Michigan Medical School in Ann Arb |
HealthDay
13 May at 03.50 PM
Study Identifies Factors Associated With Hydroxychloroquine RetinopathyFactors associated with an increased risk for hydroxychloroquine retinopathy have been identified and include female sex, older age, and chronic kidney disease stage 3 or greater, according to a study published online May 9 in JAMA Network Open.April M. Jorge, M.D., from Massachusetts General Hospital in Boston, and colleagues identified |
HealthDay
13 May at 03.46 PM
Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment InsightsPsoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal treatment, according to a study published online April 17 in the Journal of Personalized Medicine.Georgiana Strugariu, from "Grigore T. Popa" University of Medicine and Phar |
MedScape
13 May at 09.58 AM
Patient Preferences Drive Treatment Options for Early HSMost ongoing trials of HS treatments are for moderate to severe disease, Dr Jennifer L. Hsiao said. |
MedScape
13 May at 08.59 AM
Reimbursement Rates for Mohs Surgery Lag Behind InflationHealthcare delivery costs are rising, but there has been a lag in the increase in dermatologic procedure reimbursement rates. |
MedScape
13 May at 07.29 AM
Experts Share Practical Tips for Diagnosing Mild HS"Early HS can mimic an intense folliculitis or furuncles that can sometimes be caused by Staphylococcus infections," Sayed said. |
MedScape
13 May at 06.18 AM
Kids With Skin Diseases Face Stigma, Reduced Quality of LifePhysicians' assessment of disease severity and visibility may underestimate the disease's effects on the patient, data suggested. |
HealthDay
10 May at 12.42 PM
Cyberattack Cripples Major U.S. Health Care NetworkAscension, a major U.S. health care system with 140 hospitals in 19 states, announced late Thursday that a cyberattack has caused disruptions at some of its hospitals."Systems that are currently unavailable include our electronic health records system, MyChart (which enables patients to view their medical records and communicate with their provid |
MedScape
10 May at 06.19 AM
Immunosuppression Risk Factor for Poor cSCC OutcomesIn contrast to earlier findings, immunosuppression was an independent risk factor for disease-specific death and major poor outcomes. |
MedScape
09 May at 08.55 AM
Adalimumab Improves Blood Parameters in Patients With HSTreatment with adalimumab was associated with improvements in common hematologic abnormalities in patients with hidradenitis suppurativa, particularly in responders. |
MedScape
09 May at 08.47 AM
SDM in Pediatric Dermatology: Step Approach RecommendedA pediatric dermatologist proposes a four-step approach to using shared decision-making (SDM) when caring for children and adolescent patients with acne and other skin conditions. |
MedScape
09 May at 06.33 AM
Evidence Accumulating on Viral Cause of Cutaneous GranulomasOf the cases accruing in the United States and elsewhere, most but not all were linked to inborn errors of immunity. |
HealthDay
08 May at 03.29 PM
Trifarotene Plus Skin Care Beneficial for Acne VulgarisTrifarotene plus skin care is beneficial for patients with moderate acne vulgaris (AV) and acne-induced hyperpigmentation (AIH), according to a study published online April 29 in the International Journal of Dermatology.Andrew Alexis, M.D., M.P.H., from Weill Cornell Medical College in New York City, and colleagues conducted a phase IV |
HealthDay
08 May at 03.07 PM
Systemic Antibiotics in First Year of Life Tied to Higher Atopic Dermatitis RiskSystemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis (AD) risk in a dose-response fashion, according to a study published online April 24 in the Journal of Allergy and Clinical Immunology.Courtney Hoskinson, from the University of British Columbia in Vancouver, Canada, and colleagues e |
MedScape
08 May at 04.39 AM
IPC Develops Consensus on Generalized Pustular PsoriasisThe IPC's definition and diagnostic criteria for GPP minimized the complexity of clinical considerations to speed treatment of this potentially life-threatening condition. |
MedScape
07 May at 08.28 AM
Many Drugs Linked to Pediatric SJS-TEN, WHO Data ShowAntiepileptic and anti-infectious agents were the most common classes tied to SJS-TEN. |
MedScape
07 May at 05.02 AM
Some Patients More Likely to Get Opioids After Mohs SurgeryCertain minority populations may be at a higher risk of being prescribed opioids post-operatively, which may confer further risks of complications of chronic opioid use. |
MedScape
07 May at 04.19 AM
Rates of Emotional and Physical Stress High in Mohs SurgeonsAlmost three quarters of survey respondents reported experiencing psychological and emotional stress or burnout associated with being a Mohs surgeon and 68% reported a musculoskeletal injury. |
MedScape
06 May at 03.58 AM
Correct Dx of Cancer Treatment Skin Effects EvaluatedThe survey included 81 dermatologists and 182 medical oncologists at six US-based academic institutions. |
MedScape
06 May at 03.35 AM
Review Addresses Skin Manifestations of Cystic FibrosisA review covers the various skin manifestations seen in patients with CF, which include those related to the disease itself, and those associated with treatments for CF. |
MedScape
06 May at 12.01 AM
Many Patients With Advanced MCC Not Receiving ImmunotherapyDespite improved survival rates and guideline recommendations, many eligible patients with metastatic Merkel cell carcinoma are not receiving immunotherapy. |
HealthDay
02 May at 03.37 PM
Algorithm From EHR Can ID Common Variable Immunodeficiency DiseaseA machine learning algorithm can identify patients with common variable immunodeficiency disease (CVID) from their electronic health records, according to a study published in the May 1 issue of Science Translational Medicine.Due to the low prevalence and extensive heterogeneity in CVID phenotypes, resulting in delayed diagnoses and tre |
MedScape
02 May at 07.17 AM
Mpox Presentation Compared in Racial, Ethnic GroupsA retrospective review that may be the first to examine the topic found differences in mpox symptoms between White non-Hispanic patients and patients of color. |
MedScape
02 May at 07.10 AM
ILD Not Increased With MTX in Patients With DermatomyositisTreatment with methotrexate was not associated with an increased risk for interstitial lung disease (ILD) in patients with dermatomyositis. |
HealthDay
30 April at 04.12 PM
Stigma Affects Quality of Life in Children With Chronic Skin ConditionsHealth care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic skin diseases, according to a study published online April 24 in JAMA Dermatology.Amy S. Paller, M.D., from the Northwestern University Feinberg School of Medicine in Chicago, and col |
MedScape
30 April at 09.07 AM
Heat-Based Wrinkle Treatment Holds up With Facial AnesthesiaSurface anesthesia prior to thermomechanical fractional injury therapy for wrinkles around the eyes provided adequate comfort, with positive treatment outcomes, a small study found. |
MedScape
30 April at 03.39 AM
Tapinarof Cream for Adult, Pediatric Eczema Under FDA ReviewA decision on approval is expected in the fourth quarter of 2024. |
MedScape
29 April at 05.54 AM
Children With Chronic Skin Disorders Face Substantial StigmaHealthcare professionals should be aware of the possibility of stigmatization and bullying when assessing the social and mental health of children and adolescents with chronic skin disorders. |
MedScape
26 April at 07.49 AM
Prurigo Nodularis Associated With Elevated CV Risks"The potential risk of subsequent cardiovascular disease should be considered in the care of patients with PN," according to the study authors. |
MedScape
25 April at 09.28 AM
FDA Seeks More Information About RDEB Rx Under ReviewPz-cel, which comprises autologous, COL7A1 gene–corrected epidermal sheets, was designed to enable normal type VII collagen expression and facilitate wound healing and pain reduction in RDEB wounds. |
HealthDay
24 April at 07.53 PM
Tobacco Smoking Reduces the Odds of Psoriasis ImprovementTobacco smoking is negatively associated with resolution of psoriasis symptoms, according to a study published in the April issue of Tobacco Induced Diseases.Yan Qiang, from the School of Medicine at Tongji University in Shanghai, and colleagues explored the influence of smoking on treatment efficacy in patients with psoriasis. The |
MedScape
24 April at 03.16 AM
Erenumab Reduces Flushing and Erythema in RosaceaA calcitonin gene-related peptide inhibitor that is FDA-approved for migraine prevention showed early promise against treatment-resistant redness and flushing of rosacea. |
HealthDay
23 April at 03.53 PM
Atopic Dermatitis Negatively Impacts Mental HealthAtopic dermatitis (AD) negatively impacts patients’ mental health (MH), especially when a patient has severe AD, according to a study published online March 14 in Dermatitis.Jessica K. Johnson, M.P.H., from the National Eczema Association in San Rafael, California, and colleagues evaluated patient-reported MH symptoms and their c |
MedScape
22 April at 08.32 AM
Hair Loss: Experts Provide Recommendations on Oral MinoxidilThe authors "identified a need for expert-based guidelines for prescribing and monitoring LDOM use in hair loss patients." |
MedScape
22 April at 06.12 AM
Neuromodulators: Rapid-Onset Option, Other Emerging TrendsExpect intradermal injections of botulinum toxin A for the improvement in the appearance of pores, sebum, skin texture, and rosacea to gain a foothold in dermatology practices, one expert says. |
MedScape
22 April at 03.32 AM
Study Shows Faster Recovery, Less Pain With 2910-nm LaserA small study of the 2910-nm erbium-doped fluoride glass fiber laser for facial ablation showed that patients had faster recovery times and less pain than with conventional lasers. |
MedScape
22 April at 03.22 AM
Does AD Severity Affect Growth in Children?An analysis evaluated growth in a study of 1326 children with AD younger than 12 years. |
HealthDay
19 April at 03.41 PM
Review Explores Cutaneous Manifestations of Myelodysplastic SyndromeCutaneous manifestations of myelodysplastic syndrome (MDS) are described in a perspective piece published in the April issue of Skin Health and Disease.Xiang Li Tan, M.B.B.S., from St. George's University Hospitals NHS Foundation Trust in London, and colleagues conducted a systematic review to examine the prevalence, types, and prognos |
MedScape
19 April at 08.52 AM
Less PIH After Modified Laser Rx for Lentigines ReportedA 532-nm picosecond laser with fractional-beam microlens array to treat solar lentigines resulted in a lower hyperpigmentation rate in patients with darker skin types, vs the full-beam approach. |
MedScape
19 April at 04.58 AM
Registry Gives Snapshot of Cosmetic Procedure-Related AEsA registry of adverse events from dermatologic procedures found that blistering, hypopigmentation, scars, and burns are the most common complications from laser and energy devices. |
MedScape
18 April at 06.44 AM
Laser, Light Treatments Effective for PCOS-Related HirsutismLaser and light hair treatments, with and without other treatments, improve hirsutism and related psychological measures in women with PCOS. |
MedScape
18 April at 02.59 AM
Weekly Laser Treatment Promising for Port-Wine BirthmarksOnce-weekly PDL treatment in infants led to near-total or total clearance of PWB and was well-tolerated in 10 infants, suggesting further investigation of the reduced treatment interval of 1 week. |
HealthDay
17 April at 04.00 PM
Erenumab Effective, Safe for Rosacea-Linked Erythema, FlushingThe anticalcitonin gene-related peptide-receptor monoclonal antibody erenumab is effective and safe for treatment of rosacea-associated erythema and flushing, according to a study published online April 17 in JAMA Dermatology.Nita K.F. Wienholtz, M.D., Ph.D., from Copenhagen University Hospital-Rigshospitalet in Denmark, and colleag |
MedScape
17 April at 09.37 AM
Study Evaluates Time of Lung Disease Onset With Rare DMRapidly progressive interstitial lung disease was diagnosed in almost half of the patients with MDA5 antibody-positive dermatomyositis. |
MedScape
16 April at 02.08 PM
CDC Investigating Reactions Linked to Counterfeit 'Botox'Reactions have included blurry vision, double vision, drooping eyelids, difficult swallowing or breathing, and other symptoms of botulism. |
HealthDay
16 April at 11.40 AM
CDC Warns of 19 Cases of Botched Botox Shots in 9 StatesCounterfeit or mishandled Botox shots have triggered harmful reactions in 19 people in nine states, U.S. health officials warned Monday.In its alert, the U.S. Centers for Disease Control and Prevention said nine people had been hospitalized and four we |
MedScape
16 April at 06.17 AM
Survey Highlights Impact of Cosmetic-Procedure ComplicationsStudy finds that people who have complications after cosmetic procedures have higher rates of depression, anxiety, and other mental health issues than before the procedures. |
MedScape
16 April at 06.05 AM
Counterfeit Neurotoxin Investigations Prompt Call for ActionThe American Society for Dermatologic Surgery Association emphasized the risks for medical procedures in unlicensed settings. |
MedScape
16 April at 05.35 AM
Review Evaluates Data on Injectables in Skin of ColorIn this literature review, researchers found that neuromodulators and dermal fillers are useful and safe in SOC populations, although more data are needed in some groups. |
MedScape
15 April at 08.49 AM
Survey Highlights Benefits of Pediatric Derm-Rheum ClinicsPediatric dermatology-rheumatology combined clinics improve patient outcomes and satisfaction. |
MedScape
15 April at 02.03 AM
Review Suggests Skin AEs Rare With PD-1/PD-L1 InhibitorsReports of keratoacanthomas and squamous cell carcinomas associated with the use of PD-1/PD-L1 inhibitors appeared to be relatively rare. |
MedScape
15 April at 01.34 AM
Alopecia Areata: Late Responses to JAK Inhibitors ReportedResponse curves have continued to climb for as long as patients are followed, allowing many with disappointing early results to catch up, according to data presented at the AAD meeting. |
MedScape
12 April at 09.42 AM
Extension Data Reported for Chronic Hand Eczema TreatmentOver 1 year after phase 3 studies suggested that delgocitinib cream was safe and effective for chronic hand eczema, extension data indicate that control persists without new safety issues. |
MedScape
12 April at 08.58 AM
Topical Vs Oral Minoxidil for AGA: Which Is More Effective?Efficacy and safety of the two formulations were directly compared in a randomized, controlled, double-blind study of men with AGA conducted in Brazil. |
MedScape
12 April at 08.25 AM
What's Behind Long-Term Antibiotic Prescribing for Acne?"This study explored why dermatologists still prescribe a good number of long-term antibiotics for people with acne," the study's senior author Howa Yeung, MD, MSc, said in an interview. |
HealthDay
10 April at 06.15 PM
Study Identifies Factors That Affect Antibiotic Prescribing for AcneMultiple salient factors affect long-term antibiotic prescribing practices for acne, according to a study published online April 3 in JAMA Dermatology.Ronnie A. Festok, from the Emory University School of Medicine in Atlanta, and colleagues conducted a qualitative study assessing data collected from stakeholders (dermatologists, inf |
HealthDay
10 April at 03.57 PM
Bioactive Retinol Efficacious for Improving Signs of PhotoagingStabilized bioactive retinol is efficacious for improving signs of photoaging, without causing major irritation, according to a study published in the April issue of the Journal of Drugs in Dermatology.Patricia Farris, M.D., from Tulane University School of Medicine in New Orleans, and colleagues examined the comprehensive efficacy |
MedScape
10 April at 07.46 AM
New Tool Could Help Screen Patients for Zoom DysmorphiaIndividuals with zoom dysmorphia tend to scrutinize their facial features and fixate on what they think needs to improve and feel pressured to appear perfect before virtual meetings. |
MedScape
10 April at 05.22 AM
Childhood Atopic Dermatitis Linked to IBD RiskA prospective Swedish study reported that childhood atopic dermatitis is linked to an increased risk for inflammatory bowel disease. |
MedScape
09 April at 03.18 AM
Expert Recommends Phased Approach For Delusional InfestationPhase 4 involves initiating therapy, which includes demonstrating empathy by reflecting on the detrimental effects of the patient's reported sensations on their quality of life. |
MedScape
09 April at 12.35 AM
Hidradenitis Suppurativa: Sonelokimab Shows Promise in StudySonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F. |
HealthDay
08 April at 10.30 PM
FDA Approves New Antibiotic for Three IndicationsThe U.S. Food and Drug Administration has approved the antibiotic Zevtera (ceftobiprole medocaril sodium for injection) for three different indications, including treatment of adults with Staphylococcus aureus bloodstream infections, adults with acute bacterial skin and skin structure infections, and adult and pediatric patients (age 3 months |
MedScape
05 April at 08.16 AM
Transplant Recipients: Consider Skin Cancer, Infection RisksRecent research sheds light on varying skin cancer risk, and a predictive tool offers guidance on screening in solid organ transplant recipients. |
MedScape
05 April at 03.22 AM
Medicare IHC Claims With Melanoma Dxs Increased, Study FindsWith sparse guidance regarding best practices for IHC in melanoma diagnosis, more research is needed to optimize use of IHC in this setting, according to the authors. |
MedScape
05 April at 02.17 AM
FDA Accepts Application for a New HS TreatmentBimekizumab is currently approved in the United States for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. |
MedScape
04 April at 06.39 AM
Review Describes Semaglutide-Associated Skin EffectsAlopecia, dysesthesia, and other types of skin sensations have been reported in patients treated with semaglutide, but more research is needed to understand skin findings associated with this drug. |
HealthDay
03 April at 03.45 PM
Second Primary Malignancy Risk Increased After Cutaneous B-Cell LymphomaPatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a study published online March 19 in the Journal of the American Academy of Dermatology.Lauren Banner, from Thomas Jefferson University in Philadelphia, and colleagues used the Surveillance, Epidemiolo |
MedScape
03 April at 06.01 AM
Rilzabrutinib Plus Low-Dose Steroid Fails Pemphigus TrialRilzabrutinib did not meet primary or secondary endpoints in the phase 3 PEGASUS trial of patients with pemphigus vulgaris or foliaceus. |
MedScape
03 April at 03.29 AM
Ruxolitinib Cream Shows Promise for Hidradenitis SuppurativaTreatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa. |
MedScape
03 April at 02.33 AM
Intralesional Wart Treatments Are Among Options to ConsiderAlternatives to SA and cryotherapy for warts may be helpful "for patients who have failed traditional therapies or have a contraindication to the usual go-tos," said Dr Jennifer Adams. |
MedScape
02 April at 07.41 AM
JAK Inhibitors for Vitiligo: More Skin Response Over TimeTwo JAK inhibitors for non-segmental vitiligo showed better skin clearance in phase 2b trial extensions — ritlecitinib plus twice-weekly doses of UVB light and upadacitinib. |
MedScape
01 April at 01.39 AM
Tooth Enamel Disorder Is a Feature of Kindler EBStudy found that hypoplastic pitted amelogenesis imperfecta is among the oral manifestations of Kindler epidermolysis bullosa, underscoring the need for early and sustained dental care. |
MedScape
01 April at 01.16 AM
Rate of Malignancy Low in Pediatric LMPediatric longitudinal melanonychia may look like subungual melanoma in adults, but a low probability of malignancy makes clinical monitoring a reasonable noninvasive management strategy. |
HealthDay
29 March at 03.14 PM
U.S. Doctors Received Industry Payments of $12.13 Billion From 2013 to 2022U.S. physicians received $12.13 billion from industry from 2013 to 2022, according to a research letter published online March 28 in the Journal of the American Medical Association.Ahmed Sayed, M.B.B.S., from Ain Shams University in Cairo, and colleagues examined the distribution of payments within and across specialties and the medica |
HealthDay
29 March at 11.42 AM
High-Strength Lidocaine Skin Creams Can Cause Seizures, Heart Trouble, FDA WarnsSome pain-relieving skin products contain potentially harmful doses of the numbing agent lidocaine and should be avoided, the U.S. Food and Drug Administration warns.These creams, gels, sprays and soaps are marketed for topical use to relieve the pain of cosmetic procedures like microdermabrasion, laser hair removal, tattooing and <a href="http |
MedScape
27 March at 12.24 PM
FDA Warns Consumers Against Using Some Topical AnalgesicsThe warning applies to unapproved products illegally marketed for topical use to relieve pain before, during, or after cosmetic procedures. |
MedScape
26 March at 06.37 AM
Hair-Straightening Products Entail Acute Kidney Failure RiskProducts containing glyoxylic acid were associated with the accumulation of calcium oxalate crystals in the kidneys. |
HealthDay
25 March at 03.55 PM
Social Media + Photo-Editing Apps Tied to Higher Interest in Cosmetic ProceduresTime spent on social media and use of photo-editing applications contribute to the desire to undergo a cosmetic procedure, according to a study recently published in the Journal of Clinical and Aesthetic Dermatology.Iman F. Khan, M.D., M.P.H., from Boston University, and colleagues surveyed 175 adults visiting an outpatient dermat |
HealthDay
22 March at 10.09 PM
Four in 10 Adults Choose Telemedicine VisitsMany patients, including those with the greatest care needs, choose telemedicine even when in-person visits are available, according to a study published online March 22 in JAMA Network Open.Eva Chang, Ph.D., M.P.H., from Advocate Health in Milwaukee, Wisconsin, and colleagues assessed patient characteristics associated with telem |
HealthDay
22 March at 03.58 PM
Survey Assesses Perspectives on Patient Image Use in DermatologyMost patients report an increase in trust in the quality of their medical care if asked for permission to use their images for research or education, according to a research letter published online March 13 in JAMA Dermatology.Trina Salvador, from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a s |
HealthDay
22 March at 03.56 PM
Physicians Concerned About Private Equity's Impact on Health CarePhysicians express largely negative views about the impact of private equity (PE) on the health care system, according to a research letter published online March 11 in JAMA Internal Medicine.Jane M. Zhu, M.D., from Oregon Health and Science University in Portland, and colleagues conducted a survey to assess physicians' views towa |
MedScape
22 March at 01.58 AM
Acne Products With Benzoyl Peroxide Under ScrutinyIn a citizen's petition, Valisure asked the FDA to recall acne products with benzoyl peroxide, stirring debate. |
HealthDay
21 March at 10.59 PM
Life Expectancy Increased From 2021 to Reach 77.5 Years in 2022Life expectancy increased to 77.5 years in 2022, while the age-adjusted rate of drug overdose deaths increased from 2002 to 2022 but did not change from 2021 to 2022, according to two March data briefs published by the National Center for Health Statistics.Kenneth D. Kochanek, from the National Center for Health Statistics in Hyattsville, Mar |
MedScape
21 March at 09.16 AM
AI in Dermatology: Consider Its Limitations and ProblemsArtificial intelligence is coming to clinical dermatology, but its enormous promise for improving the lives of patients and physicians will depend on addressing the expected problems. |
MedScape
21 March at 07.58 AM
Immunomodulators Do Not Affect COVID-19 Vaccine EfficacyA study suggested that immunomodulatory medications do not increase the risk for COVID-19 related hospitalizations in patients who have received the COVID-19 vaccine. |
MedScape
20 March at 01.03 PM
Study Evaluates Acne Risk With Reversible ContraceptionIn the study, 28.5% of the adolescents and young adults experienced worsening acne after insertion of a progestin-only long-acting reversible contraceptive, and 17% reported acne as a new concern. |
MedScape
20 March at 07.14 AM
FDA Expands Approval of Treatment for GPPSpesolimab-sbzo was initially approved in 2022 for treating flares of generalized pustular psoriasis in adults. |
HealthDay
19 March at 11.05 PM
American Academy of Dermatology, March 8 to 12The annual meeting of the American Academy of Dermatology was held from March 8 to 12 in San Diego and attracted participants from around the world, including clinicians, academicians, allied health professionals, and others interested in dermatology. The conference highlighted recent advances in the diagnosis and management of d |
HealthDay
19 March at 03.42 PM
AAD: Continuous Improvements Seen Through 68 Weeks for Deuruxolitinib in AlopeciaFor adults with alopecia areata, continuous improvements are seen through 68 weeks with deuruxolitinib, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Brett King, M.D., Ph.D., from the Yale School of Medicine in New Haven, Connecticut, and colleagues reported po |
MedScape
19 March at 07.48 AM
Roflumilast Cream Quickly Improved AD in Children, Ages 2-5Among patients treated with roflumilast cream, 0.05%, 25.4% reached the primary endpoint of "clear" or "almost clear" plus a two-grade improvement from baseline at week 4. |
HealthDay
18 March at 03.55 PM
AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic DermatitisLebrikizumab demonstrates improvement in skin clearance and itch relief in patients with skin of color and moderate-to-severe atopic dermatitis, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Andrew Alexis, M.D., M.P.H., from Weill Cornell Medicine in New York Ci |
HealthDay
18 March at 03.52 PM
AAD: Hair Regrowth Continues to Improve at 76 Weeks With Baricitinib for Severe AlopeciaMONDAY, March 18, 2024 (HealthDay News) -- Continuous treatment with baricitinib in patients with severe alopecia areata demonstrates improvement in hair regrowth outcomes through 76 weeks of follow-up, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 12 in San Diego.Rodney D. Sinclair, M.D., from the University of Me |
MedScape
18 March at 05.46 AM
Tips on Managing Acne in Transmasculine PatientsTestosterone therapy can exacerbate symptoms, and other factors are important to consider, expert said. |
HealthDay
15 March at 03.25 PM
AAD: Adult Acne Clinic Visits Increase With Exposure to Wildfire-Related Air PollutionShort-term exposure to wildfire-related air pollution is associated with an increase in clinic visits for acne vulgaris among adults, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Alex Ha, from the University of California, San Francisco, and colleagues conducte |
HealthDay
15 March at 03.21 PM
AAD: Bimekizumab Response Durable at Four Years for Moderate-to-Severe PsoriasisFRIDAY, March 15, 2024 (HealthDay News) -- Patients with psoriasis treated with bimekizumab rapidly achieve high levels of clinical and health-related quality-of-life responses that are durable at four years, according to research presented at the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Bruce Strober, M.D., Ph.D., from the Yale Sc |
MedScape
15 March at 11.40 AM
Prurigo Nodularis: Nemolizumab Efficacy Persists at 52 WeeksThe encouraging long-term efficacy and safety associated with nemolizumab (IL-31 inhibitor) in prurigo nodularis was supported by a second set of data showing long-term benefit in atopic dermatitis. |
MedScape
15 March at 05.49 AM
Most Baby Cleansers Are Not 'Allergen-Free,' Study FindsA recent study demonstrated that 94% of top-selling baby cleansers contain allergens, despite having hypoallergenic claims. |
HealthDay
14 March at 12.04 PM
HHS Opens Investigation Into UnitedHealth CyberattackFollowing a cyberattack on one of the nation's largest health insurers that's thrown health care payments into disarray and likely exposed reams of private patient data, the U.S. Department of Health and Human Services said Wednesday it has begun an investigation into the incident.In a <a href="https://www.hhs.gov/about/news/2024/03/13/h |
MedScape
14 March at 09.07 AM
Major Responses Seen for Cicatricial and Total Hair LossTwo oral therapies targeted at kinase pathways produced meaningful responses in patients with severe types of alopecia in late-breaking studies at the American Academy of Dermatology. |
MedScape
14 March at 06.42 AM
Florida Bill Addresses Coverage of Skin Cancer ScreeningSome 321,000 state employees would be eligible, at a cost of about $357,000 per year, according to one analysis. |
HealthDay
13 March at 12.05 PM
Cyberattack Leaves Health Care Providers Reeling Weeks LaterFollowing a cyberattack on the largest health insurer in the United States last month, health care providers continue to scramble as insurance payments and prescription orders continue to be disrupted and physicians lose an estimated $100 million a day.That <a href="https://www.ama-assn.org/press-center/press-releases/cyberattack-jeopardizes |
MedScape
13 March at 07.06 AM
2024 AAD Acne Guidelines: Newer Therapies Join Old StandbysA coauthor of the new recommendations highlights updated advice and comments on worrisome benzene news. |
HealthDay
12 March at 10.49 PM
Atopic Dermatitis in Children Tied to Learning, Memory DifficultiesPediatric atopic dermatitis (AD) is associated with greater odds of reported difficulties in learning and memory, but this association is driven by children with neurodevelopmental comorbidities, according to a study published online March 6 in JAMA Dermatology.Emily Z. Ma, from the University of Maryland School of Medicine |
MedScape
12 March at 04.54 PM
Lebrikizumab Found Effective for Patients With AD, SOCInterim results at 16 weeks were based on 50 adolescents and adults with skin types IV-VI. |
MedScape
11 March at 05.36 PM
Study Eyes Effect of Maternal HS on Outcomes in OffspringThe study population included nearly 1.3 million children born in Quebec, Canada, over a 16-year period. |
MedScape
10 March at 07.53 PM
Anti-IL-17, Anti-IL-23 Rxs Show Sustained Psoriasis ControlBoth an approved anti-IL-17 therapy and an experimental oral anti-IL-23 therapy appeared to achieve relatively undiminished rates of psoriasis control in extension studies. |
MedScape
10 March at 05.01 PM
Home- and Office-Based Phototherapy for Psoriasis ComparedThe multicenter LITE trial included 783 patients at 42 sites in the United States. |
MedScape
10 March at 02.29 PM
During Pregnancy, Many Drugs Safe for Skin InfectionsSeveral drugs should be avoided or used with caution because of potential risks during pregnancy, a dermatologist told colleagues. |
MedScape
09 March at 04.07 PM
New NCCN Melanoma Guidelines Capture Evolving Best PracticeNCCN guidelines for cutaneous melanoma, issued in February, capture evolving data for both diagnosis and treatment, diverging incrementally from 2019 AAD guidelines. |
MedScape
09 March at 02.41 PM
Novel Drug Shows Promise for Hidradenitis SuppurativaThe findings suggest that Bruton's tyrosine kinase inhibition may emerge as a promising therapeutic intervention in HS. |
MedScape
08 March at 06.28 PM
Flexibility Advised for Patients With Personality DisordersUp to 15% of the general population is affected by a personality disorder, according to dermatologist, Mio Nakamura, MD. |
HealthDay
08 March at 04.59 PM
AAD: Concerns Noted Relating to Use of AI Dermatology AppsThere are notable concerns relating to the use of currently available artificial intelligence (AI) dermatology mobile applications (apps), according to a study published online March 7 in JAMA Dermatology to coincide with the annual meeting of the American Academy of Dermatology, held from March 8 to 10 in San Diego.Shannon Wongvibulsin |
MedScape
08 March at 04.07 PM
Anti-DEI Petition Sparks Conflict at Nat'l Derm MeetingA controversial proposal to end the American Academy of Dermatology diversity programs will be considered at the group's annual meeting starting today. |
MedScape
08 March at 08.01 AM
Sulfites Selected as ACDS Allergen of the YearExperts lobby for increased inclusion of sulfites in patch test panels. |
MedScape
08 March at 06.14 AM
Psoriasis Study Shows a Path for Considering US Drug CostsOnly three of 13 psoriasis biologics appeared to be cost-effective based on US prices in a new analysis. The finding may aid policymakers struggling with drug price negotiations. |
HealthDay
07 March at 02.00 PM
Carcinogen Benzene Can Form in Some Acne Treatments: ReportSome acne treatments may banish blemishes but carry hidden dangers: A new report reveals high levels of the carcinogen benzene can form in products that contain the zit-fighting ingredient benzoyl peroxide.According to the new report from |
MedScape
07 March at 07.06 AM
Is Atopic Dermatitis Linked to Cognitive Impairment Symptoms in Children?The analysis included children aged 17 years or younger without intellectual disability or autism. |
HealthDay
06 March at 04.38 PM
Skin of Color Underrepresented in AI Programs in DermatologyChallenges relating to artificial intelligence (AI) in dermatology and its application to skin of color (SOC) are partly due to underrepresentation of SOC in datasets, according to research published online March 6 in the International Journal of Dermatology.Rebecca Fliorent, from the Rowan-Virtua School of Osteopathic Medicine in St |
MedScape
06 March at 01.53 AM
New Indication Approved for JuvédermIn a randomized, controlled trial, 59% of adults reported experiencing at least one treatment site response. |
HealthDay
06 March at 12.00 AM
Tacrolimus Microemulsion Has Good Efficacy, Safety for Scalp PsoriasisFor scalp psoriasis, 0.1 percent tacrolimus microemulsion has good efficacy and safety, according to a study published online Feb. 12 in Dermatology and Therapy.Andreas Pinter, M.D., from the University Hospital Frankfurt in Germany, and colleagues conducted a multicenter, double-blind, vehicle-controlled phase 3 trial to examine the e |
HealthDay
06 March at 12.00 AM
Higher Use of Health Care Portal Seen During COVID-19 PandemicHealth care portal use was higher during the COVID-19 pandemic, according to a study published online Feb. 29 in JAMA Network Open.Esther Yoon, Ph.D., M.P.H., from the Feinberg School of Medicine at Northwestern University in Chicago, and colleagues examined the prevalence of health care portal use before, during, and after the most re |
MedScape
04 March at 10.21 PM
FDA Approves Another Neurotoxin for Frown LinesThe product has been sold in more than 50 countries, the company says. |
MedScape
03 March at 11.01 PM
Patient-Reported Outcomes Important in Cutaneous GVHD: StudyThe study results "highlight the importance of patient-reported outcomes in measuring this disease," the study's lead author said. |
MedScape
01 March at 02.06 AM
Review Highlights Evidence of Climate Change Effects on ADAtopic dermatitis "could serve as a case study for climatic impacts on health," the authors emphasized in their paper. |
MedScape
29 February at 11.18 PM
Study Finds No Increased Cancer Risk With SpironolactoneOver 5 years, treatment with spironolactone for dermatologic conditions was not associated with a greater risk for breast or gynecologic cancers, when compared with women not using spironolactone. |
MedScape
29 February at 12.45 AM
What’s The Incidence Rate of a Second Primary Melanoma?The findings may have potential implications for more personalized surveillance of patients with melanoma, the authors said. |
HealthDay
27 February at 04.59 PM
Delayed Melanoma Care During Pandemic Proved CostlyDelays in melanoma diagnoses due to COVID-19 pandemic lockdowns were associated with a significant burden, including years of life lost and costs, according to a study published online Feb. 16 in JAMA Network Open.Lara V. Maul, M.D., from University Hospital of Basel in Switzerland, and colleagues examined the consequences associa |
MedScape
27 February at 07.38 AM
What Drives Fatigue in Psoriasis and PsA?Joint pain and itch were key culprits, according to a cross-sectional analysis of Danish data. |
HealthDay
26 February at 05.02 PM
Observed Rates of Cancer Diagnoses Lower Than Expected in PandemicDuring the COVID-19 pandemic, cancer diagnoses were lower than expected, according to a study published online Feb. 22 in JAMA Oncology.Todd Burus, from the Markey Cancer Center at the University of Kentucky in Lexington, and colleagues conducted a population-based cross-sectional analysis of cancer incidence trends using data on cases |
MedScape
26 February at 01.47 AM
TikTok Info on Infantile Hemangiomas Suspect: StudyIn a cross-sectional study of the social media platform, researchers analyzed 50 videos on the topic. |
MedScape
26 February at 12.34 AM
Biologic Treatment for Psoriasis Linked to Lower MortalityEvidence to support the hypothesis that the use of systemic immunomodulatory agents for psoriasis "quenches systemic inflammation and potentially improves" survival is limited, investigators said. |
HealthDay
23 February at 11.30 PM
Level of Burnout Higher for Women in Health Care OccupationsWomen in health care occupations endure a significantly higher level of stress and burnout than men, according to a study published online Feb. 21 in Global Advances in Integrative Medicine and Health.Viktoriya Karakcheyeva, M.D., from the George Washington University School of Medicine and Health Sciences in Washington, D.C., and colle |
MedScape
23 February at 12.38 PM
EMA Approves Tx for Psoriasis and Other Autoimmune DisordersThe biosimilar Pyzchiva is highly similar to Stelara, which was approved in the EU in 2009. |
MedScape
23 February at 09.00 AM
'Superclinic' Powers Through Skin Cancer ReferralsOne hospital's experience with this model shows the efficiency of using a dedicated team (including trainees) and offering same-day biopsies and surgery. |
MedScape
23 February at 01.34 AM
Longer IV Ertapenem Course Beneficial for Recalcitrant HS2019 treatment guidelines published recommended ertapenem as a highly effective third-line therapy limited to a shorter course, as rescue therapy or during surgical planning. |
HealthDay
22 February at 12.17 PM
Jill Biden Announces $100 Million for Research on Women's HealthFirst Lady Jill Biden on Wednesday announced $100 million in federal funding to fuel research into women's health.“We will build a health care system that puts women and their lived experiences at its center,” Biden said in a White House <a href="https://www.whitehouse.gov/briefing-room/speeches-remarks/2024/02/21/remarks-as-prepared-for-deliv |
MedScape
22 February at 08.13 AM
One-a-Day Pill for Alopecia Recommended for NHS UseNICE said there is unequal treatment for people with severe alopecia areata across England and Wales and its approval of ritlecitinib could benefit up to 14,000 people. |
HealthDay
21 February at 04.01 PM
Clinical Markers Improve With IV Ertapenem for Hidradenitis SuppurativaTreatment of hidradenitis suppurativa (HS) with intravenous ertapenem is associated with improvement in clinical and inflammatory markers, according to a study published online Feb. 19 in JAMA Dermatology.Avigdor Nosrati, M.D., from the Albert Einstein College of Medicine in New York City, and colleagues conducted a retrospective rev |
HealthDay
21 February at 01.45 PM
This Election Year, Health Care Costs Top Voter Concerns: PollUnexpected medical bills and high health care costs are dominating an election where kitchen table economic problems weigh heavily on voter’s minds, a new KFF poll has found.Voters struggling to pay their monthly bills are most eager to hear presidential candidates talk about economic and health care issues, according to the latest KFF Health |
MedScape
21 February at 02.12 AM
Nemolizumab Being Reviewed for AD, Prurigo NodularisFor prurigo nodularis, the FDA has granted nemolizumab, a monoclonal antibody designed to inhibit interleukin-31 signaling, priority review. |
MedScape
20 February at 10.49 PM
What Skin Manifestations Are Associated With Pediatric IBD?Skin conditions both specific and nonspecific to IBD are prevalent in children and adolescents with IBD, with infectious conditions being the most common. |
HealthDay
20 February at 04.26 PM
Amtagvi Approved by the FDA for Treatment of Advanced MelanomaAmtagvi (lifileucel) has been approved by the U.S. Food and Drug Administration for the treatment of advanced melanoma. Amtagvi becomes the first cellular therapy approved to treat this form of solid tumor cancer."The approval of Amtagvi offers hope to those with advanced melanoma who have progressed following initial standard-of-care therapies |
HealthDay
17 February at 12.00 AM
Expanded Use of Xolair to Treat Food Allergies Approved by the FDAThe U.S. Food and Drug Administration has expanded the use of the asthma drug Xolair (omalizumab) to help prevent anaphylactic reactions.Xolair is an injected drug and is not meant as a substitute for EpiPens or other anaphylaxis rescue remedies, the agency stressed. Instead, "Xolair is intended for repeated use to reduce the risk of allergic re |
HealthDay
16 February at 04.32 PM
Deep Learning Improves Diagnostic Accuracy for Skin DiseasesDeep learning-aided decision support improves diagnostic accuracy for skin disease, according to a study published online Feb. 5 in Nature Medicine.Matthew Groh, Ph.D., from the Northwestern University Kellogg School of Management in Evanston, Illinois, and colleagues presented results from a study involving 389 board-certified dermatol |
MedScape
16 February at 12.53 AM
Cellulite: Outcomes 1 Year After Noninvasive TreatmentThe findings build on results from a 12-week study of the device, which the investigators said "induces physical shearing of fibrous septa through rapid acoustic pulses." |
MedScape
16 February at 12.02 AM
Tapinarof Under FDA Review for Treating Atopic DermatitisApproved in 2022 for psoriasis, the manufacturer has submitted an application for approval of tapinarof cream for treating atopic dermatitis in adults and children 2 years of age and older. |
HealthDay
15 February at 04.42 PM
FDA Approves Aurlumyn for Severe FrostbiteAurlumyn (iloprost), a vasodilator, has been approved by the U.S. Food and Drug Administration to treat severe frostbite. The injected medication lowers the risk for finger or toe amputation."This approval provides patients with the first-ever treatment option for severe frostbite," Norman Stockbridge, M.D., director of the Division of Cardiol |
HealthDay
14 February at 11.06 PM
Study Looks at Access to U.S. Burn Centers Using 2019 DataAccess disparities to burn centers persist, with lower access in the South and West and for those with lower income, according to a research letter published online Feb. 14 in JAMA Surgery.Dong Gi Hur, from the Stanford School of Medicine in California, and colleagues characterized access to American Burn Association (ABA)-verified a |
MedScape
14 February at 02.14 AM
Lab Testing in Patients on Immunomodulators Falls ShortReview found that fewer than 60% of patients with chronic inflammatory skin diseases underwent recommended testing before starting systemic immunomodulator treatment. |
MedScape
13 February at 11.11 PM
Tinea Capitis Management in Kids Varies, Survey FindsRespondents included 56 members of the Pediatric Dermatology Research Alliance. |
HealthDay
12 February at 04.17 PM
Link Between Inflammatory Disease, Adverse Pregnancy Outcomes VariesThe association between immune-mediated inflammatory diseases (IMIDs) and adverse pregnancy outcomes varies with the nature of IMID and the presence of comorbidities, according to a study published online Feb. 1 in eClinicalMedicine.Yeon Mi Hwang, from the Institute for Systems Biology in Seattle, and colleagues conducted a retrospectiv |
HealthDay
12 February at 04.13 PM
Smoking Linked to Melanoma-Associated Death in Early-Stage MelanomaFor patients with clinical stage I and II melanoma, smoking is associated with an increased risk for melanoma-associated death, according to a study published online Feb. 6 in JAMA Network Open.Katherine M. Jackson, M.D., from the Saint John's Cancer Institute at Providence Saint John's Health Center in Santa Monica, California, and col |
MedScape
09 February at 05.04 PM
Tools on the Horizon for Managing Posttransplant cSCC RiskOrgan transplant recipients have a 200-fold increased incidence of keratinocyte carcinoma compared with immunocompetent individuals, and cSCC accounts for 80% of skin cancers in those recipients. |
HealthDay
09 February at 04.56 PM
Health Care Costs, Resource Utilization Increased for Vitiligo PatientsPatients with vitiligo have significantly higher health care costs and health care resource utilization (HCRU), according to a study recently published in the Journal of Investigative Dermatology.Khaled Ezzedine, M.D., from Henri Mondor University Hospital in Créteil, France, and colleagues conducted a retrospective cohort analysis |
MedScape
09 February at 04.42 PM
Analysis Finds Allergens in Many Topical Scar ProductsOf the 156 products identified, most were gels, creams, or oils. |
MedScape
09 February at 05.44 AM
Spitz Nevi: An Expert Shares Tips for Diagnosis, ManagementDr Caroline Piggott provides her perspective on dermoscopy, shave vs punch biopsies, and treatment. |
MedScape
09 February at 02.26 AM
Periocular Melanoma Still Rare, But May Be IncreasingPain and vision loss are late symptoms of periocular melanoma, and there are amelanotic variants. |